LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article: Be mindful of potential pitfalls when using the Cre-LoxP system in cancer research.

    Czarnota, Piotr / Cisowski, Jaroslaw

    Oncoscience

    2023  Volume 10, Page(s) 67–68

    Language English
    Publishing date 2023-11-14
    Publishing country United States
    Document type Editorial
    ISSN 2331-4737
    ISSN 2331-4737
    DOI 10.18632/oncoscience.591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Correction: Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination.

    Gromowski, Tomasz / Lukacs-Kornek, Veronika / Cisowski, Jaroslaw

    Cancer cell international

    2023  Volume 23, Issue 1, Page(s) 31

    Language English
    Publishing date 2023-02-21
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2091573-1
    ISSN 1475-2867
    ISSN 1475-2867
    DOI 10.1186/s12935-023-02875-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination.

    Gromowski, Tomasz / Lukacs-Kornek, Veronika / Cisowski, Jaroslaw

    Cancer cell international

    2023  Volume 23, Issue 1, Page(s) 3

    Abstract: Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are devastating primary liver cancers with increasing prevalence in many parts of the world. Despite intense investigation, many aspects of their biology are still largely obscure. For example, ...

    Abstract Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are devastating primary liver cancers with increasing prevalence in many parts of the world. Despite intense investigation, many aspects of their biology are still largely obscure. For example, numerous studies have tackled the question of the cell-of-origin of primary liver cancers using different experimental approaches; they have not, however, provided a clear and undisputed answer. Here, we will review the evidence from animal models supporting the role of all major types of liver epithelial cells: hepatocytes, cholangiocytes, and their common progenitor as liver cancer cell-of-origin. Moreover, we will also propose mechanisms that promote liver cancer cell plasticity (dedifferentiation, transdifferentiation, and epithelial-to-mesenchymal transition) which may contribute to misinterpretation of the results and which make the issue of liver cancer cell-of-origin particularly complex.
    Language English
    Publishing date 2023-01-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2091573-1
    ISSN 1475-2867
    ISSN 1475-2867
    DOI 10.1186/s12935-022-02843-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: What makes oncogenes mutually exclusive?

    Cisowski, Jaroslaw / Bergo, Martin O

    Small GTPases

    2017  Volume 8, Issue 3, Page(s) 187–192

    Abstract: Cancer is driven by mutations in genes whose products participate in major signaling pathways that fuel cell proliferation and survival. It is easy to assume that the more of these so-called driver mutations a tumor accumulates, the faster it progresses. ...

    Abstract Cancer is driven by mutations in genes whose products participate in major signaling pathways that fuel cell proliferation and survival. It is easy to assume that the more of these so-called driver mutations a tumor accumulates, the faster it progresses. However, this does not appear to be the case: Data from large-scale genome sequencing studies indicate that mutations in driver oncogenes often are mutually exclusive. The mechanisms underlying the mutual exclusivity of oncogenes are not completely understood, but recent reports suggest that the mechanisms may depend on the tumor type, and the nature of interacting oncogenes. Here we discuss our recent findings that the oncogenes KRAS
    MeSH term(s) Animals ; Cell Death/genetics ; Cellular Senescence/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Mutation ; Neoplasms/genetics ; Neoplasms/pathology ; Oncogenes/genetics
    Language English
    Publishing date 2017--03
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2682247-7
    ISSN 2154-1256 ; 2154-1248
    ISSN (online) 2154-1256
    ISSN 2154-1248
    DOI 10.1080/21541248.2016.1212689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Percutaneous treatment of right heart endocarditis.

    Sacha, Jerzy / Lipski, Przemysław / Bugajski, Jarosław / Marszalski, Maciej / Gwóźdź, Witold / Płonka, Joanna / Tomaszewski, Paweł / Cisowski, Marek / Gierlotka, Marek

    Kardiologia polska

    2023  Volume 81, Issue 10, Page(s) 1028–1029

    MeSH term(s) Humans ; Endocarditis/diagnostic imaging ; Endocarditis/surgery ; Endocarditis, Bacterial/diagnostic imaging ; Endocarditis, Bacterial/drug therapy ; Endocarditis, Bacterial/surgery ; Heart ; Treatment Outcome
    Language English
    Publishing date 2023-08-04
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.a2023.0176
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Knockout of the RAS endoprotease RCE1 accelerates myeloid leukemia by downregulating GADD45b.

    Karlsson, Christin / Akula, Murali K / Staffas, Anna / Cisowski, Jaroslaw / Sayin, Volkan I / Ibrahim, Mohamed X / Lindahl, Per / Bergo, Martin O

    Leukemia

    2020  Volume 35, Issue 2, Page(s) 606–609

    MeSH term(s) Animals ; Antigens, Differentiation/chemistry ; Antigens, Differentiation/genetics ; Antigens, Differentiation/metabolism ; Down-Regulation ; Endopeptidases/physiology ; Leukemia, Myeloid/etiology ; Leukemia, Myeloid/metabolism ; Leukemia, Myeloid/pathology ; Mice ; Mice, Knockout
    Chemical Substances Antigens, Differentiation ; Gadd45b protein, mouse ; Endopeptidases (EC 3.4.-) ; Rce1 protein, mouse (EC 3.4.22)
    Language English
    Publishing date 2020-05-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-020-0859-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Overexpression of biliverdin reductase enhances resistance to chemotherapeutics.

    Florczyk, Urszula / Golda, Slawomir / Zieba, Agata / Cisowski, Jaroslaw / Jozkowicz, Alicja / Dulak, Jozef

    Cancer letters

    2011  Volume 300, Issue 1, Page(s) 40–47

    Abstract: Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR functions, ...

    Abstract Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR functions, we used genetically modified line of mouse fibroblasts with reversible overexpression of BVR. Current study revealed that enhanced activity of BVR may protect cells in stressful conditions arising from anti-cancer drugs, cisplatin and doxorubicin, the effect most probably related to PKC α/β activity, as its inhibition reversed BVR action. Therefore activity of BVR may be of significance in tumors and may influence the effectiveness of therapies.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Cisplatin/pharmacology ; Dose-Response Relationship, Drug ; Doxycycline/pharmacology ; Drug Resistance, Neoplasm ; Heme Oxygenase-1/genetics ; Membrane Proteins/genetics ; Mice ; NIH 3T3 Cells ; Oxidoreductases Acting on CH-CH Group Donors/physiology ; Protein Kinase C/physiology
    Chemical Substances Antineoplastic Agents ; Membrane Proteins ; Heme Oxygenase-1 (EC 1.14.14.18) ; Hmox1 protein, mouse (EC 1.14.14.18) ; Oxidoreductases Acting on CH-CH Group Donors (EC 1.3.-) ; biliverdin reductase (EC 1.3.1.24) ; Protein Kinase C (EC 2.7.11.13) ; Doxycycline (N12000U13O) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2011-01-01
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2010.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Overexpression of biliverdin reductase enhances resistance to chemotherapeutics

    Florczyk, Urszula / Golda, Slawomir / Zieba, Agata / Cisowski, Jaroslaw / Jozkowicz, Alicja / Dulak, Jozef

    Cancer letters. 2011 Jan. 1, v. 300, no. 1

    2011  

    Abstract: Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR functions, ...

    Abstract Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR functions, we used genetically modified line of mouse fibroblasts with reversible overexpression of BVR. Current study revealed that enhanced activity of BVR may protect cells in stressful conditions arising from anti-cancer drugs, cisplatin and doxorubicin, the effect most probably related to PKC α/β activity, as its inhibition reversed BVR action. Therefore activity of BVR may be of significance in tumors and may influence the effectiveness of therapies.
    Keywords bilirubin ; cisplatin ; doxorubicin ; fibroblasts ; mice ; neoplasms ; serine ; signal transduction ; threonine ; transcription factors
    Language English
    Dates of publication 2011-0101
    Size p. 40-47.
    Publishing place Elsevier Ireland Ltd
    Document type Article
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2010.09.003
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.

    Loboda, Agnieszka / Jazwa, Agnieszka / Grochot-Przeczek, Anna / Rutkowski, Andrzej J / Cisowski, Jaroslaw / Agarwal, Anupam / Jozkowicz, Alicja / Dulak, Jozef

    Antioxidants & redox signaling

    2008  Volume 10, Issue 10, Page(s) 1767–1812

    Abstract: Heme oxygenase-1, an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been recognized as playing a crucial role in cellular defense against stressful conditions, not only related to heme release. HO-1 protects endothelial cells from ... ...

    Abstract Heme oxygenase-1, an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been recognized as playing a crucial role in cellular defense against stressful conditions, not only related to heme release. HO-1 protects endothelial cells from apoptosis, is involved in blood-vessel relaxation regulating vascular tone, attenuates inflammatory response in the vessel wall, and participates in blood-vessel formation by means of angiogenesis and vasculogenesis. The latter functions link HO-1 not only to cardiovascular ischemia but also to many other conditions that, like development, wound healing, or cancer, are dependent on neovascularization. The aim of this comprehensive review is to address the mechanisms of HO-1 regulation and function in cardiovascular physiology and pathology and to demonstrate some possible applications of the vast knowledge generated so far. Recent data provide powerful evidence for the involvement of HO-1 in the therapeutic effect of drugs used in cardiovascular diseases. Novel studies open the possibilities of application of HO-1 for gene and cell therapy. Therefore, research in forthcoming years should help to elucidate both the real role of HO-1 in the effect of drugs and the clinical feasibility of HO-1-based cell and gene therapy, creating the effective therapeutic avenues for this refined antioxidant system.
    MeSH term(s) Animals ; Apoptosis ; Biliverdine/metabolism ; Carbon Monoxide/metabolism ; Carbon Monoxide/pharmacology ; Carbon Monoxide/toxicity ; Cardiovascular Agents/pharmacology ; Cardiovascular Agents/therapeutic use ; Cardiovascular Diseases/drug therapy ; Cardiovascular Diseases/enzymology ; Cardiovascular Diseases/therapy ; Child ; Diabetes Complications/enzymology ; Diabetes Complications/prevention & control ; Diabetes Complications/therapy ; Endothelium, Vascular/enzymology ; Enzyme Induction/drug effects ; Enzyme Induction/radiation effects ; Female ; Genetic Therapy ; Heme/metabolism ; Heme Oxygenase-1/chemistry ; Heme Oxygenase-1/deficiency ; Heme Oxygenase-1/genetics ; Heme Oxygenase-1/physiology ; Humans ; Inflammation/enzymology ; Inflammation/therapy ; Iron/metabolism ; Male ; Mice ; Mice, Knockout ; Neovascularization, Physiologic ; Rabbits ; Rats ; Vasomotor System/drug effects
    Chemical Substances Cardiovascular Agents ; Heme (42VZT0U6YR) ; Carbon Monoxide (7U1EE4V452) ; Iron (E1UOL152H7) ; Heme Oxygenase-1 (EC 1.14.14.18) ; Biliverdine (O9MIA842K9)
    Language English
    Publishing date 2008-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1483836-9
    ISSN 1557-7716 ; 1523-0864
    ISSN (online) 1557-7716
    ISSN 1523-0864
    DOI 10.1089/ars.2008.2043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress.

    Jozkowicz, Alicja / Was, Halina / Taha, Hevidar / Kotlinowski, Jerzy / Mleczko, Katarzyna / Cisowski, Jaroslaw / Weigel, Guenter / Dulak, Jozef

    Antioxidants & redox signaling

    2008  Volume 10, Issue 12, Page(s) 2035–2046

    Abstract: 15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) is a cyclopentenone prostaglandin regarded as antiinflammatory mediator, which can act through peroxisome proliferator-activated receptor-gamma (PPARgamma) or through G protein-coupled surface ... ...

    Abstract 15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) is a cyclopentenone prostaglandin regarded as antiinflammatory mediator, which can act through peroxisome proliferator-activated receptor-gamma (PPARgamma) or through G protein-coupled surface receptors. It has been demonstrated that 15d-PGJ(2) potently increases the generation of interleukin-8 (IL-8) in human microvascular endothelial cells (HMEC-1s); however, the mechanism of this induction is not known. The aim of the study was to find the pathway involved in 15d-PGJ(2)-mediated IL-8 stimulation. Our data confirmed that the effect of 15d-PGJ(2) is independent of PPARgamma. For the first time, we excluded the activation of G proteins and the contribution of G protein-coupled surface receptors in endothelial cells treated with 15d-PGJ(2). Instead, we demonstrated that stimulation of IL-8 involved induction of oxidative stress, activation of p38 kinases, and increase in stability of IL-8 mRNA. Upregulation of IL-8 promoter, although measurable, seemed to play a less-pronounced role. Additionally, our results indicate the involvement of cAMP elevation and may suggest a role for ATF2 transcription factor. Concomitant induction of heme oxygenase-1 in HMEC-1s did not influence the synthesis of IL-8. In summary, we showed that 15d-PGJ(2), acting through oxidative stress, may exert proinflammatory effects. The upregulation of IL-8 is mostly associated with p38-mediated stabilization of mRNA.
    MeSH term(s) Acetylcysteine/pharmacology ; Cells, Cultured ; Colforsin/pharmacology ; Cyclic AMP/antagonists & inhibitors ; Cyclic AMP/metabolism ; Endothelial Cells/cytology ; Endothelial Cells/drug effects ; Endothelial Cells/metabolism ; Enzyme-Linked Immunosorbent Assay ; Ethacrynic Acid/pharmacology ; Ethylmaleimide/analogs & derivatives ; Ethylmaleimide/pharmacology ; Gene Expression/drug effects ; Hemin/pharmacology ; Humans ; Hydantoins/pharmacology ; Interleukin-8/genetics ; Interleukin-8/metabolism ; Oxidative Stress/drug effects ; Prostaglandin D2/analogs & derivatives ; Prostaglandin D2/pharmacology ; Protein Kinase Inhibitors/pharmacology ; RNA Stability/drug effects ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reactive Oxygen Species/metabolism ; Receptors, Prostaglandin/agonists ; Receptors, Prostaglandin/antagonists & inhibitors ; Reverse Transcriptase Polymerase Chain Reaction ; Superoxide Dismutase/genetics ; Superoxide Dismutase/metabolism ; Transfection ; Xanthones/pharmacology ; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors ; p38 Mitogen-Activated Protein Kinases/metabolism
    Chemical Substances 15-deoxyprostaglandin J2 ; Hydantoins ; Interleukin-8 ; Protein Kinase Inhibitors ; RNA, Messenger ; Reactive Oxygen Species ; Receptors, Prostaglandin ; Xanthones ; prostanoid D receptor 1, human ; Colforsin (1F7A44V6OU) ; 6-isopropoxy-9-oxoxanthene-2-carboxylic acid (33458-93-4) ; Hemin (743LRP9S7N) ; BW 245C (75693-75-3) ; Cyclic AMP (E0399OZS9N) ; Superoxide Dismutase (EC 1.15.1.1) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; Ethacrynic Acid (M5DP350VZV) ; Ethylmaleimide (O3C74ACM9V) ; Prostaglandin D2 (RXY07S6CZ2) ; Acetylcysteine (WYQ7N0BPYC)
    Language English
    Publishing date 2008-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1483836-9
    ISSN 1557-7716 ; 1523-0864
    ISSN (online) 1557-7716
    ISSN 1523-0864
    DOI 10.1089/ars.2008.2032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top